ASH 2019: Study investigated factors where patients may benefit from a second infusion of CAR T therapy.
Home / Resource Library / Factors Associated with Response, CAR-T Cell In Vivo Expansion, and Progression-Free Survival after Repeat Infusions of CD19 CAR-T Cells